Impact of thrombolytic therapy on hemoglobin change after acute myocardial infarction.
Tahnk-Johnson
M E
ME
Cardiology Division, Hennepin County Medical Center, Minneapolis, Minnesota.
Sharkey
S W
SW
D001815:Bloodletting; D005260:Female; D006438:Hemodilution; D006454:Hemoglobins / Q000032:analysis*; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D012307:Risk Factors; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D006454:Hemoglobins; D006493:Heparin; D010959:Tissue Plasminogen Activator